Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers.
Publication/Presentation Date
4-1-2023
Abstract
Eph receptors, the largest known family of receptor tyrosine kinases, and ephrin ligands have been implicated in a variety of human cancers. The novel bidirectional signaling events initiated by binding of Eph receptors to their cognate ephrin ligands modulate many cellular processes such as proliferation, metastasis, angiogenesis, invasion, and apoptosis. The relationships between the abundance of a unique subset of Eph receptors and ephrin ligands with associated cellular processes indicate a key role of these molecules in tumorigenesis. The combinatorial expression of these molecules converges on MAP kinase and/or AKT/mTOR signaling pathways. The intracellular target proteins of the initial signal may, however, vary in some cancers. Furthermore, we have also described the commonality of up- and down-regulation of individual receptors and ligands in various cancers. The current state of research in Eph receptors illustrates MAP kinase and mTOR pathways as plausible targets for therapeutic interventions in various cancers.
Volume
104
First Page
110579
Last Page
110579
ISSN
1873-3913
Published In/Presented At
Lau, A., Le, N., Nguyen, C., & Kandpal, R. P. (2023). Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers. Cellular signalling, 104, 110579. https://doi.org/10.1016/j.cellsig.2022.110579
Disciplines
Medicine and Health Sciences
PubMedID
36572189
Department(s)
Fellows and Residents
Document Type
Article